Church T S, Willis M S, Priest E L, Lamonte M J, Earnest C P, Wilkinson W J, Wilson D A, Giroir B P
The Cooper Institute, 12330 Preston Road, Dallas, TX 75230, USA.
Int J Obes (Lond). 2005 Jun;29(6):675-81. doi: 10.1038/sj.ijo.0802942.
Elevated macrophage migration inhibitory factor (MIF) has been implicated as a causal mechanism in a number of disease conditions including cardiovascular disease (CVD), diabetes, and cancer. Excess body fat is associated with an increased risk of numerous health conditions including CVD, diabetes, and cancer. To our knowledge, the association between MIF and obesity status and the effect of weight loss on serum MIF concentrations have not been reported. In this study, we examined the effects of participation in a behavior-based weight loss program on MIF concentrations in obese individuals.
Study participants were 71 men and women enrolled in The Cooper Institute Weight Management Program. Participants were predominantly female (68%, n=48), middle-aged (46.5+/-9.8 y), and severely obese (BMI=43.0+/-8.6).
Plasma MIF concentrations and other standard risk factors were measured before and after participation in a diet and physical activity based weight management program.
The mean follow-up was 8.5+/-3.0 months with an average weight loss of 14.4 kg (P<0.001). The majority of clinical risk factors significantly improved at follow-up. Median levels of plasma MIF concentration were significantly lower at follow-up (median [IQR]; 5.1[3.6-10.3]) compared to baseline (8.4 [4.3-48.8]; P=0.0005). The percentage of participants with plasma MIF concentration > or =19.5 mg/nl (highest tertile at baseline) decreased from 33.8 to 5.6% (P<0.001). Further, elevated baseline plasma MIF concentration was associated with markers of beta-cell dysfunction and reductions in MIF were associated with improvements in beta-cell function.
Circulating MIF concentrations are elevated in obese but otherwise healthy individuals; however, this elevation in MIF is not uniform across individuals. In obese individuals with elevated circulating MIF concentrations, participation in physical activity and a dietary-focused weight management program resulted in substantial reduction in MIF.
巨噬细胞移动抑制因子(MIF)水平升高被认为是包括心血管疾病(CVD)、糖尿病和癌症在内的多种疾病状态的致病机制。过多的体脂与包括CVD、糖尿病和癌症在内的多种健康状况风险增加相关。据我们所知,MIF与肥胖状态之间的关联以及体重减轻对血清MIF浓度的影响尚未见报道。在本研究中,我们考察了参与基于行为的体重减轻计划对肥胖个体MIF浓度的影响。
研究参与者为71名参加库珀研究所体重管理计划的男性和女性。参与者以女性为主(68%,n = 48),为中年(46.5±9.8岁),且为重度肥胖(BMI = 43.0±8.6)。
在参与基于饮食和体育活动的体重管理计划前后,测量血浆MIF浓度及其他标准风险因素。
平均随访时间为8.5±3.0个月,平均体重减轻14.4 kg(P<0.001)。大多数临床风险因素在随访时显著改善。与基线水平(8.4 [4.3 - 48.8];P = 0.0005)相比,随访时血浆MIF浓度的中位数水平显著降低(中位数[四分位间距];5.1[3.6 - 10.3])。血浆MIF浓度≥19.5 mg/nl(基线时最高三分位数)的参与者百分比从33.8%降至5.6%(P<0.001)。此外,基线血浆MIF浓度升高与β细胞功能障碍标志物相关,而MIF降低与β细胞功能改善相关。
肥胖但其他方面健康的个体循环MIF浓度升高;然而,这种MIF升高在个体间并不一致。在循环MIF浓度升高的肥胖个体中,参与体育活动和以饮食为主的体重管理计划可使MIF大幅降低。